Chemed (CHE) PT Raised to $667 at RBC Capital, Citing 'Continued VITAS Momentum'
Tweet Send to a Friend
RBC Capital analyst Ben Hendrix raised the price target on Chemed (NYSE: CHE) to $667.00 (from $633.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
